DAYBUE (trofinetide)
RETT SYNDROME AGENTS - GLYPROMATE (GPE) ANALOGS · RETT SYNDROME
ACADIA PHARMACE
Drug class
Rett Syndrome Agents - Glypromate (GPE) Analogs
Rett syndrome agents – glypromate (GPE) analogs are a specialized class of neuroactive therapeutics chemically derived from glycine-proline-glutamate, the endogenous N-terminal tripeptide cleaved from insulin-like growth factor 1. Read more about Rett Syndrome Agents - Glypromate (GPE) Analogs
2 drugs in this class 1 manufacturers
Drugs in Rett Syndrome Agents - Glypromate (GPE) Analogs
DAYBUE STIX (trofinetide)
RETT SYNDROME AGENTS - GLYPROMATE (GPE) ANALOGS · RETT SYNDROME
ACADIA PHARMACE
Filter & compare in the drug finder →
Opens the drug finder with Rett Syndrome Agents - Glypromate (GPE) Analogs preselected. Add indication or manufacturer filters there.
Rett syndrome agents – glypromate (GPE) analogs are a specialized class of neuroactive therapeutics chemically derived from glycine-proline-glutamate, the endogenous N-terminal tripeptide cleaved from insulin-like growth factor 1.
Exemplified by trofinetide, these synthetic peptidomimetics are designed with enhanced metabolic stability and bioavailability compared to natural GPE.
While their exact molecular mechanism of action in humans is not fully elucidated, these agents are thought to support synaptic maturation, normalize dendritic morphology, reduce neuroinflammation, and modulate glial cell overactivation.
Clinically, this drug class is indicated specifically for the treatment of Rett syndrome, a rare genetic neurodevelopmental disorder characterized by progressive loss of motor, communication, and cognitive function.
-
fda.gov
Rett syndrome agents – glypromate (GPE) analogs are a specialized class of neuroactive therapeutics chemically derived from glycine-proline-glutamate, the endogenous N-terminal tripeptide cleaved from insulin-like growth factor 1
-
fda.gov
Rett syndrome agents – glypromate (GPE) analogs are a specialized class of neuroactive therapeutics chemically derived from glycine-proline-glutamate, the endogenous N-terminal tripeptide cleaved from insulin-like growth factor 1
-
nih.gov
Exemplified by trofinetide, these synthetic peptidomimetics are designed with enhanced metabolic stability and bioavailability compared to natural GPE
-
patsnap.com
Exemplified by trofinetide, these synthetic peptidomimetics are designed with enhanced metabolic stability and bioavailability compared to natural GPE While their exact molecular mechanism of action in humans is not fully elucidated, these agents are thought to support synaptic maturation, normalize dendritic morphology, reduce neuroinflammation, and modulate glial cell overactivation
-
aan.com
While their exact molecular mechanism of action in humans is not fully elucidated, these agents are thought to support synaptic maturation, normalize dendritic morphology, reduce neuroinflammation, and modulate glial cell overactivation
-
fda.gov
Clinically, this drug class is indicated specifically for the treatment of Rett syndrome, a rare genetic neurodevelopmental disorder characterized by progressive loss of motor, communication, and cognitive function
-
caresource.com
Clinically, this drug class is indicated specifically for the treatment of Rett syndrome, a rare genetic neurodevelopmental disorder characterized by progressive loss of motor, communication, and cognitive function
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.